PMC:7076992 / 1139-2072
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T11 | 497-506 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T12 | 658-662 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 307-310 | http://purl.obolibrary.org/obo/CLO_0050884 | denotes | ten |
T4 | 345-348 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T5 | 444-447 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T6 | 551-561 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 84-101 | Chemical | denotes | anti-viral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
T6 | 113-124 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T7 | 152-163 | Chemical | denotes | ganciclovir | http://purl.obolibrary.org/obo/CHEBI_465284 |
T8 | 203-222 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T9 | 203-212 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T10 | 213-222 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T11 | 421-432 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T12 | 433-442 | Chemical | denotes | phosphate | http://purl.obolibrary.org/obo/CHEBI_18367|http://purl.obolibrary.org/obo/CHEBI_26020|http://purl.obolibrary.org/obo/CHEBI_35780|http://purl.obolibrary.org/obo/CHEBI_43474 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 497-506 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-45 | Sentence | denotes | Classes Potential treatment options Reference |
T12 | 46-256 | Sentence | denotes | Anti-viral > 85% of patients received anti-viral agents, including oseltamivir (75 mg every 12 h orally), ganciclovir (0.25 g every 12 h intravenously), and lopinavir/ritonavir tablets (400/100 mg twice daily). |
T13 | 257-384 | Sentence | denotes | Remdesivir is currently under trials at more than ten medical institutions in Wuhan and has been known to prevent MERS-CoV. [1] |
T14 | 385-566 | Sentence | denotes | Anti-malarial An old anti-malarial, chloroquine phosphate, has been effective in inhibiting the exacerbation of pneumonia due to its anti-viral and anti-inflammatory activities. [3] |
T15 | 567-716 | Sentence | denotes | Herbal treatments There was widespread use of Traditional Chinese Medicine during the last SARS-COV outbreak and it is currently being used in China. |
T16 | 717-933 | Sentence | denotes | The five most commonly used herbs were Astragali Radix (Huangqi), Glycyrrhizae Radix Et Rhizoma (Gancao), Saposhnikoviae Radix (Fangfeng), Atractylodis Macrocephalae Rhizoma (Baizhu), and Lonicerae Japonicae Flo. [4] |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32178711-32081636-23646624 | 382-383 | 32081636 | denotes | 1 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
32 | 658-666 | Species | denotes | SARS-COV | Tax:694009 |
33 | 66-74 | Species | denotes | patients | Tax:9606 |
34 | 371-379 | Species | denotes | MERS-CoV | Tax:1335626 |
35 | 113-124 | Chemical | denotes | oseltamivir | MESH:D053139 |
36 | 152-163 | Chemical | denotes | ganciclovir | MESH:D015774 |
37 | 203-222 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
38 | 257-267 | Chemical | denotes | Remdesivir | MESH:C000606551 |
39 | 421-442 | Chemical | denotes | chloroquine phosphate | MESH:C023676 |
40 | 497-506 | Disease | denotes | pneumonia | MESH:D011014 |
41 | 869-890 | Disease | denotes | Macrocephalae Rhizoma |